High materiality7/10
H.C. Wainwright Reiterates Buy Rating on Corbus Pharmaceuticals (CRBP)
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy with a target of $35; CRBP trades near $11.31.
- Target $35
- Current price $11.31
- H.C. Wainwright
Key facts
- 01
Target: $35
- 02
Posted price: $11.31
- 03
Analyst firm: H.C. Wainwright
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.